Display options
Share it on

J Pain Res. 2016 Sep 29;9:721-725. doi: 10.2147/JPR.S112947. eCollection 2016.

Prolongation of greater occipital neural blockade with 10% lidocaine neurolysis: a case series of a new technique.

Journal of pain research

David Daewhan Kim, Nabil Sibai

Affiliations

  1. Department of Anesthesiology/Pain Medicine Division, Henry Ford Hospital, Detroit, MI, USA.

PMID: 27729811 PMCID: PMC5047742 DOI: 10.2147/JPR.S112947

Abstract

INTRODUCTION: Greater occipital nerve blocks (GONB) have been used for headache but their benefit may be short. Ready et al performed intrathecal injections on rabbits and reported neurologic/histologic changes that required concentrations of at least 8%. Our study tests the hypothesis that the neurolytic effects of GONB with 10% lidocaine can prolong relief.

METHODS: After an approval from Henry Ford Hospital Institutional Review Board, a chart review was performed for patients who had GONB with 10% lidocaine. Patients received 10% lidocaine after short response (<1 month / >50% relief) to GONB with 1 cc of a solution containing 9 mL 0.5 % bupivacaine and 40 mg methylprednisolone. They received a block with 10% lidocaine with volume given at <80% of the maximum dose of 4 mg/kg. Injections were performed under fluoroscopic guidance after injection of 0.1 cc of contrast (isovue or magnevist). All patients had intravenous access and were given fentanyl and midazolam. The visual analog scale (VAS) scores were recorded on follow-up, and the duration of response was noted. VAS changes with 10% lidocaine and comparison of duration with methylprednisolone were performed using paired

RESULTS: Thirteen patients were reviewed; 12 were female and the mean age was 47. Ten were diagnosed with migraine, and three with occipital neuralgia; 12 had bilateral symptoms. Baseline VAS prior to 10% lidocaine averaged 86.92 mm. The mean volume injected per nerve was 1.096 mL. There was significant decrease in mean% VAS with 10% lidocaine at 60.4% (mean: -52.69 mm) (

CONCLUSION: Ten percent lidocaine may be a useful neurolytic agent in prolonging the duration of GONB.

Keywords: injections; intractable headaches; migraines; occipital neuralgia; pain relief

References

  1. Anesth Analg. 1993 May;76(5):1154-7 - PubMed
  2. Cephalalgia. 2006 Jan;26(1):50-5 - PubMed
  3. Anesthesiology. 1994 Sep;81(3):657-67 - PubMed
  4. Reg Anesth Pain Med. 1998 Sep-Oct;23(5):444-50 - PubMed
  5. Case Rep Neurol Med. 2014;2014:257373 - PubMed
  6. Headache. 2010 Jun;50(6):937-42 - PubMed
  7. Curr Pain Headache Rep. 2003 Oct;7(5):377-83 - PubMed
  8. J Pain Res. 2014 Apr 10;7:195-8 - PubMed
  9. Reg Anesth Pain Med. 1998 Jan-Feb;23(1):96-100 - PubMed
  10. Anesthesiology. 1994 May;80(5):1082-93 - PubMed
  11. Reg Anesth Pain Med. 2012 Nov-Dec;37(6):601-6 - PubMed
  12. Acta Anaesthesiol Scand. 2000 Mar;44(3):285-90 - PubMed
  13. J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):808-11 - PubMed
  14. Br J Surg. 1970 Jan;57(1):45-50 - PubMed
  15. Pain Med. 2006 Sep-Oct;7(5):453-6 - PubMed
  16. Pain Pract. 2006 Dec;6(4):278-84 - PubMed
  17. Headache. 2014 Mar;54(3):500-10 - PubMed
  18. Anesthesiology. 1989 Nov;71(5):757-62 - PubMed
  19. Headache. 2005 Apr;45(4):350-4 - PubMed
  20. Pain. 2006 May;122(1-2):126-9 - PubMed
  21. Prague Med Rep. 2011;112(4):279-87 - PubMed
  22. Pain. 1978 Oct;5(3):205-29 - PubMed
  23. Korean J Pain. 2016 Jul;29(3):158-63 - PubMed
  24. Anesth Analg. 2013 Sep;117(3):731-9 - PubMed
  25. Eur J Neurol. 2014 Feb;21(2):338-43 - PubMed
  26. Anesth Analg. 2009 Mar;108(3):997-1007 - PubMed
  27. Anesth Analg. 1998 Mar;86(3):569-73 - PubMed
  28. Anesthesiology. 1985 Oct;63(4):364-70 - PubMed
  29. Acta Anaesthesiol Scand. 2007 Jan;51(1):101-7 - PubMed
  30. J Headache Pain. 2010 Dec;11(6):519-23 - PubMed
  31. Cephalalgia. 2015 Oct;35(11):959-68 - PubMed
  32. Reg Anesth. 1995 Sep-Oct;20(5):363-8 - PubMed
  33. Reg Anesth Pain Med. 2011 Sep-Oct;36(5):444-51 - PubMed
  34. J Neuropathol Exp Neurol. 1993 May;52(3):234-40 - PubMed

Publication Types